Medical Protozoology
A branch of medical microbiology that deals with the study of Protozoa which are parasites of humans. The parasites of humans in the kingdom protozoa are now classified under 3 phyla: Sarcomastigophora (containing the amoebas and flagellates); Apicomplexa (containing the sporozoans); and Ciliophora (containing the ciliates).
Protozoa are ubiquitous in moist areas, including the human alimentary canal. Although most amoebas are free-living, several are found as commensal inhabitants of the intestinal tract in humans. One of these organisms Entamoeba histolytica may invade tissue and produce disease. The majority of ciliates are free living and seldom parasitize humans. Flagellates of the genus Trypanosomes and Leishmania are capable of invading the blood & tissue of humans, where they produce severe chronic illness. Others such as Trichomonas vaginalis and Giardia lamblia, inhabit the urogenital and gastrointestinal tracts and initiate disease characterized by mild to moderate morbidity but no mortality.
- Malaria
- Amoebiasis
- Giardiasis
- Cryptosporidiosis
- Balantidiasis
- Isosporiosis
- Cyclosporiasis
- Trichomoniasis
- Toxoplasmosis
- Trypanosomiasis
- Leishmaniasis
- Amoebic Meningoencephalitis
Related Conference of Medical Protozoology
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Medical Protozoology Conference Speakers
Recommended Sessions
- Agriculture and Veterinary Parasitology
- Bacterial Pathogenesis
- Biochemical and molecular Parasitology
- Diagnostic Parasitology
- Field Parasitology
- Fungal Pathogenesis
- Immunoparasitology
- Medical Entomology
- Medical Helminthology
- Medical Protozoology
- Parasitic Diseases: Control
- Parasitic diseases: Pharmacology
- Parasitic Zoonoses
- Public Health Parasitology
- Tropical Diseases
- Vector-borne diseases
- Viral Pathogenesis
- Wildlife and Fisheries Parasitology
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)

